Somatuline Depot (lanreotide) — Medica
Carcinoid syndrome
Initial criteria
- Medication is prescribed by or in consultation with an oncologist, endocrinologist, or gastroenterologist
Reauthorization criteria
- Prescriber continues to be an oncologist, endocrinologist, or gastroenterologist
- Continued need for treatment as determined by clinical assessment
Approval duration
1 year